HEOR Theater - External Control Arms – The Case for a Standardized Lexicon and Toolkit

November 18, 2021

Open to all ISPOR Members and Non-members

Presented by

  • Sumeet Bakshi. PhD, MBA
  • Artak Khachatryan, PhD

November 18, 2021
10:00AM EST | 3:00PM GMT | 4:00PM CET 

Click here for time zone conversion

Both the FDA and EMA have made statements that support the concept of using real world evidence (RWE) for regulatory decision-making. Historical control arms represent a way to take a safe and effective leap forward into real-world evidence. But there is much heterogeneity in the lexicon (eg. external, historical, synthetic) and the tools used (eg. natural history cohorts, disease registries, placebo arms of clinical trials, simulated cohorts, artificial intelligence).  During this presentation, the speakers will present a case for a common language and the need for a robust toolkit that supports planning and design of external control arms.

Learning Objectives:

  • The context for external control arms - regulatory/HTA
  • A discussion of key terms related to external control arms and available tools
  • Key design considerations for external control arms and suggestions to harmonize/clarify language and methods
  • Demonstrate a “toolkit” approach with the use of case studies

Register Here 

Sponsored by: Certara 


Sumeet Bakshi, PhD, MBA, VP, Real World Data Solutions, Certara, London, UK

Artak Khachatryan, PhD, Senior Director, Pharmaco-Epidemiology, Certara, London, UK

Please note: On the day of the scheduled HEOR Theater, the first 1000 registered participants will be accepted. For those who are unable to attend, or would like to review the HEOR Theater On-Demand at a later date, please register using the link above to access the full-length recording. 

Reservations are on a first-come, first-served basis.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now